Erratum to: Chemical profiling of deoxyhypusine hydroxylase inhibitors for antimalarial therapy (Amino Acids (2013) 45, (1047-1053) DOI: 10.1007/s00726-013-1575-0);Chemical profiling of deoxyhypusine hydroxylase inhibitors for antimalarial therapy

Amino Acids

Volumn 45, Issue 5, 2013, Pages 1047-1053

  Von Koschitzky, Imke ^a   Kaiser, Annette ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Deoxyhypusine hydroxylase; DOHH inhibitors; Hypusine; Malaria; Phenotypic screening

Indexed keywords

ANTIMALARIAL AGENT; DEOXYHYPUSINE HYDROXYLASE INHIBITOR; GAMMA INTERFERON; HYPUSINE; UNCLASSIFIED DRUG;

ANTIMALARIAL DRUG SUSCEPTIBILITY; BRAIN MALARIA; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG RESPONSE; HUMAN; IC 50; NONHUMAN; PHENOTYPE; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM OVALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; REVIEW;

EUKARYOTA; MAMMALIA; PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; ENZYME INHIBITORS; HUMANS; MALARIA; MIXED FUNCTION OXYGENASES;

EID: 84886278855     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-014-1689-z     Document Type: Erratum

References (37)

1. Atemnkeng VA, Pink M, Schmitz-Spanke S, Wu XJ, Dong LL, Zhao KH, May C, Laufer S, Langer B, Kaiser A (2013) Deoxyhypusine hydroxylase from plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileuton. PLoS One 8(3):e58318. doi: 10.1371
2. Basco LK, Le Bras J (1994) Short-term in vitro culture of plasmodium vivax and P. ovale for drug-susceptibility testing. Parasitol Res 80(3):262-264 (Pubitemid 24127033)
3. Cameron A, Read J, Tranter R, Winter VJ, Sessions RB, Brady RL, Vivas L, Easton A, Kendrick H, Croft SL, Barros D, Lavandera JL, Martin JJ, Risco F, García-Ochoa S, Gamo FJ, Sanz L, Leon L, Ruiz JR, Gabarró R, Mallo A, Gómez de las Heras F (2004) Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed antimalarial activity. J Biol Chem 23, 279(30):31429-31439 (Pubitemid 39037810)
4. Craig AG, Grau GE, Janse C (2012) The role of animal models for research on severe malaria. PLoS Pathog 8(2):e1002401. doi: 10.1371/journal.ppat.1002401
5. Diaz CA, Allocco J, Powles MA, Yeung L, Donald RG, Anderson JW, Liberator PA (2006) Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor. Mol Biochem Parasitol 146(1):78-88 (Pubitemid 43132805)
6. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ (2009) Artemisinin resistance in plasmodium falciparum malaria. N Engl J Med 30, 361(5):455-467
7. Dyshlovoy SA, Naeth I, Venz S et al (2012) Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with anti-proliferative activity. J Proteome Res 11(4):2316-2330
8. Gamo FJ, Sanz LM, Vidal J, de Cozar C (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465:305-310
9. Granchi C, Bertini S, Macchia M, Minutolo F (2010) Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials. Curr Med Chem 17(7):672-697
10. Guiguemde WA, Shelat AA, Garcia-Bustos JF, Diagana TT, Gamo FJ, Guy RK (2012) Global phenotypic screening for antimalarials. Chem Biol 19(1):116-129. doi: 10.1016/j.chembiol.2012.01.004
11. Hauber I, Bevec D, Heukeshoven J, Krätzer F, Horn F, Choidas A, Harrer T, Hauber J (2005) Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest 115(1):76-85 (Pubitemid 40385507)
12. Hofmann W, Reichart B, Ewald A, Müller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC (2001) Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J Cell Biol 152(5):895-910. doi: 10.1083/jcb.152.5.895 (Pubitemid 34286067)
13. Husek P (1991) Rapid derivatization and gas chromatographic determination of amino acids. J Chromatogr 552:289-299
14. Kaiser A, Khomutov AR, Simonian A, Agostinelli E (2012) A rapid and robust assay for the determination of the amino acid hypusine as a possible biomarker for a high-throughput screening of antimalarials and for the diagnosis and therapy of different diseases. Amino Acids 42(5):1651-1659
15. Katoh M, Yokoi T (2007) Application of chimeric mice with humanized liver for predictive ADME. Drug Metab Rev 39(1):145-157
16. Kerscher B, Nzukou E, Kaiser A (2010) Assessment of deoxyhypusine hydroxylase as a putative, novel drug target. Amino Acids 38(2):471-477
17. Kossodo S, Grau GE (1993) Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 151:4811-4820 (Pubitemid 23318534)
18. Maier B, Tersey SA, Mirmira RG (2010) Hypusine: a new target for therapeutic intervention in diabetic inflammation. Discov Med 10(50):18-23
19. malERA Consultative Group on Drugs et al. (2011) A research agenda for malaria eradication: drugs. PLoS Med 8(1):1-9
20. Mittal N, Subramanian G, Bütikofer P, Madhubala R (2013) Unique posttranslational modifications in eukaryotic translation factors and their roles in protozoan parasite viability and pathogenesis. Mol Biochem Parasitol 187(1):21-31
21. Nie CQ, Bernard NJ, Schofield L, Hansen DS (2007) CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect Immun 75(5):2275-2282 (Pubitemid 46744315)
22. Park JH, Wolff EC, Park MH (2011) Assay of deoxyhypusine hydroxylase activity. Meth Mol Biol 720:207-216
23. Penna-Coutinho J, Cortopassi WA, Oliveira AA, França TC, Krettli AU (2011) Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies. PLoS One 6(7):e21237
24. Rosorius O, Reichart B, Krätzer F, Heger P, Dabauvalle MC, Hauber J (1999) Nuclear pore localization and nucleocytoplasmic transport of eIF-5A: evidence for direct interaction with the export receptor CRM1. J Cell Sci 112(Pt 14):2369-2380 (Pubitemid 29381027)
25. Rossi A, Pergola C, Koeberle A, Hoffmann M, Dehm F (2010) The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages. Br J Pharmacol 161:555-570
26. Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT (2010) Spiroindolones, a potent compound class for the treatment of malaria. Science 3, 329(5996):1175-1180
27. Sanchez CP, Pfahler J, Del Portillo HA, Lanzer M (2013) Transient transfection of plasmodium vivax blood-stage parasites. Meth Mol Biol 923:151-159
28. Sánchez-Jiménez F, Ruiz-Pérez MV, Urdiales JL, Medina MA (2013) Pharmacological potential of biogenic amine-polyamine interplay beyond neurotransmission. Br J Pharmacol. doi: 10.1111/bph.12109
29. Sasaki K, Abid MR, Miyazaki M (1996) Deoxyhypusine synthase gene is essential for cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett 384(2):151-154 (Pubitemid 26139793)
30. Schwentke A, Krepstakies M, Mueller AK, Hammerschmidt-Kamper C, Motaal BA, Bernhard T, Hauber J, Kaiser A (2012) In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway. BMC Microbiol 12:107. doi: 10.1186/1471-2180-12-107
31. + T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 1989(112):161-182 (Pubitemid 20048812)
32. Shiba T, Mizote H, Kaneko T, Nakajima T, Kakimoto Y (1971) Hypusine, a new amino acid occurring in bovine brain. Isolation and structural determination. Biochim Biophys Acta 21, 244(3):523-531
33. Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TN, Willis P (2013) The open access malaria box: a drug discovery catalyst for neglected diseases. Plos One 8(6):e62906
34. Sutherland CJ, Tanomsing N, Nolder D et al (2010) Two non-recombining sympatric forms of the human malaria parasite plasmodium ovale occur globally. J Infect Dis 15, 201(10):1544-1550. doi: 10.1086/652240
35. Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10:507-519
36. White NJ (2008) Plasmodium knowlesi: the fifth human malaria parasite. Clin Infect Dis 46:172-173 (Pubitemid 351269153)
37. Zhang W, Purchio AF, Chen K et al (2003) A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene. Drug Metab Dispos 31:1054-1064 (Pubitemid 36975677)